CLINICAL_TRIALS
trial_result
· 2019-01-14
Clinical Trial Update: Does Sevoflurane Cause Genomic Damage [Phase 4]
Summary
A Phase 4 clinical trial investigating whether sevoflurane exposure causes genomic damage, sponsored by Jubilee Mission Medical College and Research Institute, …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jubilee Mission Medical College and Research Institute | Conditions: Anesthesia; Adverse Effect | Phase 4 | Status: UNKNOWN